Clinical Trial Update: The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining whether AST-120 improves endothelial dysfunction in patients with chronic kidney disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Ewha Womans University | Conditions: Kidney Failure, Chronic | Phase 4 | Status: UNKNOWN